Sheeba K. Thomas

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Sheeba K. Thomas
Apr 11, 2025, 15:47 | Blog
Major microbiome disruption and Toxicities Following Idecabtagene Vicleucel in Multiple Myeloma patients
Muzaffar Qazilbash, Professor of Medicine at UT- MD Anderson Cancer Center, shared a post on…
Mar 7, 2025, 13:11 | Blog
Khalis Mustafayev: Are selected Hepatitis C-associated indolent lymphomas curable with antivirals alone?
Khalis Mustafayev, Medical Oncology and Research Scientist at Miami Cancer Institute, posted on LinekdIn about…
Jan 3, 2025, 13:22 | Science
Myeloma Paper of the Day, January 3rd, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Study of standard-risk myeloma…
Nov 2, 2024, 14:46 | Insight
Myeloma Paper of the Day, November 2nd, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Study of optimal infused CD34+…
Oct 26, 2024, 09:18 | Insight
Myeloma Paper of the Day, October 26th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Study of real-world outcomes of upfront ASCT…
Aug 14, 2024, 11:56 | Insight
Myeloma Paper of the Day, August 14th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase 1 trial of personalized…
Jun 10, 2024, 15:38 | Insight
Myeloma Paper of the Day, June 10th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: MD Anderson Cancer Center study of…
May 18, 2024, 15:37 | Insight
Myeloma Paper of the Day, May 18th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Myeloma patients with long remission post-ASCT…
All: 8 Posts: 1 - 100
Special Coverage